tiprankstipranks
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX
US Market
PTGX
Protagonist Therapeutics
RESEARCH TOOLSreports

Protagonist Therapeutics (PTGX) Income Statement

735 Followers

Protagonist Therapeutics Income Statement

Last quarter (Q4 2025), Protagonist Therapeutics's total revenue was $7.44M, a decrease of -95.64% from the same quarter last year. In Q4, Protagonist Therapeutics's net income was $-44.38M. See Protagonist Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 46.02M$ 434.43M$ 60.00M$ 26.58M$ 27.36M
Gross Profit
$ 44.79M$ 434.43M$ 60.00M$ 26.58M$ 27.36M
Operating Expenses
$ 202.92M$ 181.59M$ 153.65M$ 157.95M$ 153.20M
Depreciation and Amortization
$ 1.23M$ 826.00K$ 3.31M$ 3.37M$ 2.77M
EBITDA
$ -128.09M$ 253.67M$ -90.34M$ -128.00M$ -123.07M
Operating Income
$ -158.13M$ 252.84M$ -93.65M$ -131.37M$ -125.84M
Other Income/Expenses
$ 28.82M$ 26.57M$ 14.70M$ 3.98M$ 294.00K
Pretax Income
$ -129.31M$ 279.41M$ -78.95M$ -127.39M$ -125.55M
Net Income
$ -130.15M$ 275.19M$ -78.95M$ -127.39M$ -125.55M
Per Share Metrics
Basic EPS
$ -2.05$ 4.47$ -1.39$ -2.52$ -2.65
Diluted EPS
$ -2.05$ 4.23$ -1.39$ -2.52$ -2.65
Weighted Average Shares Outstanding
 63.57M 61.57M 56.76M 49.04M 46.32M
Weighted Average Shares Outstanding (Diluted)
 63.57M 65.08M 56.76M 49.04M 46.32M
Currency in USD

Protagonist Therapeutics Earnings and Revenue History